Related Experiment Videos
[NF-kappa B as a therapeutic drug target]
1Department of Pharmacology, Teikyo University, School of Medicine, 2-11-1 Kaga, Itabashi-ku, Tokyo 173-8605, Japan. hisikawa@med.teikyo-u.ac.jp
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica
|October 2, 2001
Summary
Nuclear Factor kappa B (NF-kappa B) is a key transcription factor involved in diseases. This review discusses NF-kappa B inhibitors and their potential for developing new therapeutic agents.
Area of Science:
- Molecular Biology
- Immunology
- Pharmacology
Background:
- Nuclear Factor kappa B (NF-kappa B) is a crucial transcription factor with complex regulation.
- It controls diverse genes and biological responses, and is implicated in various human diseases.
- NF-kappa B's evolutionary conservation highlights its fundamental biological role.
Purpose of the Study:
- To review the current understanding of NF-kappa B inhibitors.
- To explore the potential of NF-kappa B as a drug discovery target.
- To discuss the development of novel therapeutic agents targeting NF-kappa B.
Main Methods:
- Literature review of studies on NF-kappa B.
- Analysis of NF-kappa B regulation and function.
- Examination of existing and potential NF-kappa B inhibitors.
Main Results:
- NF-kappa B is activated by a wide array of stimuli.
- Its dysregulation is linked to numerous diseases.
- Several classes of NF-kappa B inhibitors have been identified.
Conclusions:
- NF-kappa B inhibitors represent a promising therapeutic strategy.
- Further research is needed to optimize drug development for NF-kappa B.
- Targeting NF-kappa B holds potential for treating various inflammatory and cancerous diseases.